ARIX

ARIX BIOSCIENCE PLC ORD 0.001P

TitleTime
Amplyx closes $53 million Series C extensionWed 20/05/20 | 07:00
Notice of Annual General MeetingTue 12/05/20 | 07:00
Pharmaxis announces new data in myelofibrosisTue 28/04/20 | 09:23
Harpoon doses first patient in multiple myeloma trialMon 27/04/20 | 13:12
Director/PDMR ShareholdingFri 17/04/20 | 14:59
Autolus announces FDA acceptance of IND applicationThu 16/04/20 | 13:08
Changes to Board of Directors and executive leadershipMon 06/04/20 | 07:00
Director/PDMR ShareholdingMon 16/03/20 | 07:00
Imara prices Nasdaq IPOThu 12/03/20 | 07:11
Annual Results for the year ended 31 December 2019Tue 10/03/20 | 07:00
Dr Roberto Iacone appointed as EiRMon 09/03/20 | 12:00
Update on Imara proposed IPO in the United StatesTue 03/03/20 | 12:18
Notice of ResultsThu 27/02/20 | 12:00
Aura announces updated Phase 1b/2 clinical dataMon 24/02/20 | 13:26
Imara files for proposed IPO in the United StatesMon 17/02/20 | 07:00
Autolus presents encouraging additional AUTO3 dataThu 30/01/20 | 12:08
Arix co-founds Quench Bio with Series A financingMon 27/01/20 | 07:00
Autolus announces pricing of public offeringThu 23/01/20 | 07:00
Iterum announces $52 million private placementFri 17/01/20 | 13:15
Pharmaxis business updateWed 18/12/19 | 10:00
Board changesTue 17/12/19 | 10:57
Iterum announces topline Phase 3 dataWed 11/12/19 | 07:05
Autolus announces new AUTO3 data at ASHMon 09/12/19 | 07:01
Autolus announces key new data at ASHMon 09/12/19 | 07:00
Holding(s) in CompanyFri 22/11/19 | 09:57
Harpoon and AbbVie announce licensing and option dealThu 21/11/19 | 12:06
Autolus reports Q3 2019 financial resultsThu 07/11/19 | 12:22
Change of BrokerThu 07/11/19 | 07:22
Autolus to present new data at the ASH Annual MeetingWed 06/11/19 | 14:31
Artios expands DDR pipeline with new assetWed 06/11/19 | 07:02
Holding(s) in CompanyThu 17/10/19 | 13:40
Aura reports updated Phase 1b/2 clinical data for AU-011Wed 16/10/19 | 08:00
]Holding(s) in CompanyTue 15/10/19 | 15:20
2019 Capital Markets DayThu 03/10/19 | 07:06
Management changeWed 02/10/19 | 07:00
Arix co-leads EUR 20m Series A financing in STipeMon 30/09/19 | 07:00
Amplyx unveils expanded pipeline and Phase 2 dataTue 17/09/19 | 07:47
Interim results for the six months ended 30 June 2019Wed 28/08/19 | 07:00
Notice of ResultsTue 20/08/19 | 07:25
Autolus reports Q2 2019 financial resultsThu 08/08/19 | 13:03
Total Voting RightsThu 01/08/19 | 07:00
Holding(s) in CompanyMon 08/07/19 | 15:34
Issue of Ordinary Shares, TVR, PDMR NotificationsWed 03/07/19 | 07:00
Holding(s) in CompanyFri 28/06/19 | 15:22
Holding(s) in CompanyTue 25/06/19 | 16:17
Holding(s) in CompanyTue 18/06/19 | 17:23
Correction: Result of AGMMon 03/06/19 | 17:51
Result of AGMMon 03/06/19 | 17:16
Total Voting RightsMon 03/06/19 | 07:00
Director/PDMR ShareholdingFri 10/05/19 | 07:00
Issue of Ordinary Shares and Total Voting RightsWed 01/05/19 | 07:00
Autolus announces closing of public offeringTue 16/04/19 | 07:00
Autolus announces pricing of public offeringThu 11/04/19 | 07:00
Autolus announces launch of proposed public offeringTue 09/04/19 | 07:00
Aura completes $40 million Series D financingTue 02/04/19 | 07:08
Autolus presents initial AUTO1 data at AACRMon 01/04/19 | 18:10
Annual Results for the year ended 31 December 2018Thu 28/03/19 | 07:00
Board changesThu 28/03/19 | 07:00
Autolus hosts R&D day and provides update on AUTO3Tue 26/03/19 | 10:17
Notice of ResultsWed 20/03/19 | 12:23
Arix co-leads $63m Series B investment round for ImaraMon 18/03/19 | 07:00
Autolus announces updated results from CARPALL trialTue 19/02/19 | 12:12
Management and Board changesTue 19/02/19 | 07:00
Harpoon closes initial public offeringThu 14/02/19 | 07:00
Harpoon prices Nasdaq IPOFri 08/02/19 | 07:09
Total Voting RightsFri 01/02/19 | 10:38
Update on Harpoon proposed IPO in the United StatesTue 29/01/19 | 14:25
Issue of Ordinary Shares and Total Voting RightsThu 03/01/19 | 07:00
Harpoon announces proposed public offering in the USFri 28/12/18 | 07:00
Arix appoints Dr Christian Schetter as EIRTue 11/12/18 | 07:00
Autolus presents initial AUTO3 clinical data at ASHMon 03/12/18 | 07:00
Autolus announces update on AUTO4 and AUTO5 programmesMon 03/12/18 | 07:00
Positive Phase 1 clinical trial resultsThu 15/11/18 | 07:00
Arix invests in $70m Harpoon Series C investment roundMon 12/11/18 | 07:00
Autolus Therapeutics to Present New Data at the ASHFri 02/11/18 | 11:33
Aura Biosciences reports positive Phase 1b/2 dataTue 30/10/18 | 14:11
LogicBio announces closing of initial public offeringWed 24/10/18 | 07:00
LogicBio prices Nasdaq IPOFri 19/10/18 | 07:00
Update on LogicBio proposed IPO in the United StatesWed 10/10/18 | 07:00
Co-leads $58 million Series A for VelosBioMon 01/10/18 | 07:00
LogicBio files registration for proposed IPO in the USWed 26/09/18 | 07:00
Update on Iterum Therapeutics Phase 3 trialsTue 18/09/18 | 14:00
Announces Board ChangesWed 12/09/18 | 16:30
Holding(s) in CompanyMon 10/09/18 | 16:24
Changes announced to executive teamTue 04/09/18 | 07:00
Holdings in Company and Lock-in AgreementFri 17/08/18 | 13:01
Positive clinical progression in Group BusinessesFri 10/08/18 | 07:01
Artios completes £65m Series B investment roundFri 10/08/18 | 07:00
Arix Bioscience announces first VIPE investmentMon 06/08/18 | 07:00
Interim Results for the Six Months Ended 30 June 2018Mon 30/07/18 | 07:00
Notice of ResultsWed 25/07/18 | 16:41
Total Voting RightsMon 02/07/18 | 13:16
Autolus annouces closing of IPOTue 26/06/18 | 17:30
Autolus Announces Pricing of Initial Public OfferingFri 22/06/18 | 07:07
Issue of Shares, Total Voting Rights & PDMR NotificationThu 21/06/18 | 10:22
Director/PDMR ShareholdingMon 11/06/18 | 16:23
Update on Autolus proposed NASDAQ IPOFri 08/06/18 | 11:36
Lord John Hutton steps down from Board of DirectorsThu 31/05/18 | 14:00
Iterum Therapeutics plc Closes Initial Public OfferingWed 30/05/18 | 16:13
Iterum Therapeutics plc Prices Initial Public OfferingFri 25/05/18 | 07:19
Result of AGMThu 17/05/18 | 12:29
Update on Iterum proposed NASDAQ IPOThu 17/05/18 | 07:00
Autolus Files for Proposed US IPOTue 08/05/18 | 07:00
Arix notes Iterum?s proposed US IPOWed 02/05/18 | 10:10
Annual Results 2017Mon 23/04/18 | 07:00
Notice of Annual ResultsMon 16/04/18 | 07:25
Holding(s) in CompanyWed 04/04/18 | 09:01
Total Voting RightsWed 04/04/18 | 09:00
Holding(s) in CompanyMon 26/03/18 | 13:40
Holding(s) in CompanyFri 23/03/18 | 09:00
Holding(s) in CompanyThu 22/03/18 | 11:51
Holdings in CompanyWed 21/03/18 | 12:46
Director/PDMR ShareholdingWed 21/03/18 | 11:40
Holding(s) in CompanyWed 21/03/18 | 11:39
Results of General MeetingFri 16/03/18 | 11:45
Results of Capital RaisingFri 16/03/18 | 07:00
Publication of a ProspectusWed 28/02/18 | 11:29
Proposed Firm Placing, Placing and OfferWed 28/02/18 | 07:00
Arix Bioscience and Ipsen sign strategic agreementWed 21/02/18 | 07:00
Arix signs strategic agreement with FosunMon 19/02/18 | 07:00
Voting Rights and Capital: Month End DisclosureWed 03/01/18 | 09:46
Issue of Ordinary Shares, TVR, PDMR ShareholdingFri 22/12/17 | 07:00
Arix co-leads $30m financing for Aura BiosciencesThu 21/12/17 | 07:00
Arix Bioscience leads $30m financing for Atox BioMon 04/12/17 | 07:00
Sir John Banham retires from Board of DirectorsFri 10/11/17 | 09:00
Giles Kerr Appointed to Board of DirectorsTue 17/10/17 | 07:00
Arix participates in $80 million Autolus financingTue 26/09/17 | 07:00
Arix participates in $67m financing for AmplyxWed 02/08/17 | 07:00
Report for the Six Months Ended 30 June 2017Mon 31/07/17 | 07:00
Arix Bioscience: $29M Series A for PreciTheraThu 27/07/17 | 07:00
Meghan FitzGerald appointed to Board of DirectorsFri 21/07/17 | 15:17
Notice of ResultsMon 17/07/17 | 07:00
Arix Bioscience leads $45M financing roundWed 28/06/17 | 07:00